Back
Lexeo Therapeutics, Inc. 10K Form
Sell
49
LXEO
Lexeo Therapeutics, Inc.
Last Price:
$9.42
Seasonality Move:
-53.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LXEO News And Ratings
See the #1 stock for the next 7 days that we like better than LXEO
LXEO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-29.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.20 |
| Price / Book: | 2.57 |
Profitability
| EPS (TTM): | -2.70170 |
|---|---|
| Net Income (TTM): | $-105M |
| Gross Margin: | $-2M |
| Return on Equity: | -86.99% |
| Return on Assets: | -68.21% |
Lexeo Therapeutics, Inc. Earnings Forecast
Key Lexeo Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 0 years.
Lexeo Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LXEO |
| Website: | lexeotx.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 7.4 |
| Quick Ratio: | 7.11 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LXEO Technical Analysis vs Fundamental Analysis
Sell
49
Lexeo Therapeutics, Inc. (LXEO)
is a Sell
Is Lexeo Therapeutics, Inc. a Buy or a Sell?
-
Lexeo Therapeutics, Inc. stock is rated a SellThe current Lexeo Therapeutics, Inc. [LXEO] share price is $9.35. The Score for LXEO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.